Coughlin Timothy
SEC Form 4 insider trading activity
Coughlin Timothy has filed 6 SEC Form 4 filings (11 transaction rows) across 3 companies, including TVTX, VIR, ADCT, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 16, 2026.
On the most recent filing, Coughlin Timothy is listed as Director at Travere Therapeutics, Inc. Inside the rolling window, Coughlin Timothy reported no open-market purchases and 3 open-market sales totaling $1.3M in TVTX. The largest disclosed transaction in the window is a sale of 18,000 TVTX shares on Oct 31, 2025, worth $631K.
Companies traded
Other insiders at TVTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Coughlin Timothy made?
Coughlin Timothy has filed 6 SEC Form 4 filings (11 transaction rows) across 3 companies, including TVTX, VIR, ADCT since 2025.
Which companies does Coughlin Timothy trade?
Coughlin Timothy has filed SEC Form 4 disclosures for 3 companies, including TVTX, VIR, ADCT.
When was Coughlin Timothy's most recent SEC Form 4 filing?
Coughlin Timothy's most recent SEC Form 4 filing on Tracefour is dated Jun 16, 2026.
What is Coughlin Timothy's total buy and sell value in the current window?
Inside the rolling retention window, Coughlin Timothy bought $0 and sold $1.3M based on SEC Form 4 filings.
What was Coughlin Timothy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,000 TVTX shares on 2025-10-31, worth $631K, per SEC Form 4 filings.